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Theadvancementofmicrobialprocessesfortheproductionofrenewableliquidfuelshasincreasedwithconcernsaboutthecurrent
fuel economy. The development of advanced biofuels in particular has risen to address some of the shortcomings of ethanol. These
advanced fuels have chemical properties similar to petroleum-based liquid fuels, thus removing the need for engine modiﬁcation
orinfrastructureredesign.Whiletheproductivityandtitersofeachoftheseprocessesremainstobeimproved,progressinsynthetic
biology has provided tools to guide the engineering of these processes through present and future challenges.
1.Introduction
The desire for the discovery of renewable liquid fuels,
as well as commodity chemicals, has escalated due to
the environmental impact, supply security, and decreasing
total reserve of petroleum-based fuels and chemicals [1].
Petroleum consumption reached 37.1 quadrillion BTU in
the United States in 2008, of which a large majority (71%)
was used as a liquid fuel in the transportation sector [2].
This has lead to an increased focus to ﬁnd sustainable
replacements or supplements to petroleum derived diesel
fuel, jet fuel, and motor gasoline [3–5]. The largest eﬀort
thus far has been the production of ethanol, which is often
used as a supplement to gasoline but is also available in
high percentage blends such as E85. Ethanol production via
fermentation reached 9.2 billion gallons in the United States
in 2008, an increase of over 40% from 2007 [2]. According
to the newest Renewable Fuels Standard (RFS2) set aside
in 2010, the mandate for renewable fuels production is 36
billion gallons by 2022. These renewable fuels are classiﬁed
into 4 categories: cellulosic biofuels, which must be derived
from renewable lignocellulosics and achieve a 60% lifecy-
cle greenhouse gas (GHG) emission reduction over their
petroleum-derived counterparts; biomass-based diesel (50%
GHG emission reduction); advanced biofuels, which consist
of any renewable fuel other than corn ethanol that reduces
GHG emissions by 50%; total renewable fuel, of which any
fuel that achieves a 20% reduction of GHG emissions is
counted [6]. Of the biomass-derived diesel fuels, biodiesel
has gained momentum as a supplement or replacement to
traditional petrodiesel, with production reaching just under
700 million gallons in 2008 [2]. Biodiesel can be made by
several methods, but is most commonly synthesized by the
transesteriﬁcation of oils and fat triglycerides with methanol
to make fatty acid methyl esters (FAME).
Although each of these fuel alternatives provides initial
platforms for biofuel development, their increased commer-
cializationtoreplacepetroleumisnotwithoutitslimitations.
Ethanol is incompatible with the current fuel infrastructure,
and the supply of raw materials for biodiesel production
from plant oils and waste animal fats may become a concern.
These opportunities for reﬁnement have lead researchers to
look for alternative fuels and production processes to replace
petroleum derived fuels, including fermentative alcohols [7–
12], nonfermentative higher chain alcohols [13], isoprenoid
[14] and lipid fuels [15–18], and fuels synthesized directly
fromCO2 viaphotosynthesis[19,20].Thesemicrobial-based
processes are critical ﬁrst steps in designing processes to
provide renewable drop-in liquid fuels.
Aiding in the design and continued development of these
processes,amongahostofothers,hasbeensyntheticbiology.
Syntheticbiologyaimstodesign,synthesize,andcharacterize
new biological elements, or redesign natural systems, that
can be lumped together in a “toolbox.” These elements2 Journal of Biomedicine and Biotechnology
can include promoters [21–23], regulatory proteins and
RNAs [24–28], and scaﬀolds [29, 30]. With this “toolbox,”
syntheticbiologistsassembletheseindividuallycharacterized
parts into hierarchal structures to perform new, novel, or
nonnative tasks [31], such as synthetic oscillators [32]a n d
toggle switches [33]. This “toolbox” also allows for the
investigation of several designs to achieve the same function,
often with varying levels of success, as in the case of
heterologous 1-butanol production [7, 9, 10]. This diﬀers
from traditional engineering approaches in that the design
focal point is on the core components, which can be ﬁne-
tuned to meet strict guidelines for speciﬁc tasks [34]. Much
of the work accomplished in biofuel research until now has
relied on the identiﬁcation of target pathways and the design
of synthetic expression systems for enzymes responsible for
fuel production. As these technologies progress and mature,
the design, implementation, and optimization of new func-
tions, as well as the upgrading and rewiring of existing
components,willbeessentialforthesuccessfuldiscoveryand
production of new biofuels, as many challenges still limit
theirproductivity.Thisreviewwillinvestigaterecentprogress
made in the microbial production of biofuels to supplant
petrodiesel and motor gasoline and will discuss how existing
and newly developed synthetic biology tools may aid in the
advancement of these processes.
2. CurrentBiofuels Research
2.1. Traditional Fermentative Processes. Ethanol, isopro-
panol, and 1-butanol are the only naturally produced
alcohol biofuels. Isopropanol can be used directly as a fuel
supplement to gasoline or as a feedstock for the transester-
iﬁcation of fats into biodiesel [35]. Both isopropanol and
1-butanol are produced in a mixed product fermentation
in various strains of Clostridium [36], with maximum
production levels reaching 2g/L and 20g/L, respectively
[37, 38]. With a renewed interest in alternative fuels, the
production of isopropanol and 1-butanol has been recently
investigated in genetically tractable heterologous organisms.
These organisms, such as Escherichia coli and Saccharomyces
cerevisiae, facilitate the design and optimization of new
biofuels processes by combining an increasing synthetic
biologytoolboxwithawell-studiedmetabolism.Isopropanol
production in E. coli has surpassed that of Clostridium
by assembling the pathway for acetone production and a
secondary alcohol dehydrogenase [8, 12]. The production of
1-butanol, however, has proven to be more diﬃcult. Initial
eﬀorts were able to produce ∼0.5g/L using E. coli as a
host [7]. Construction of a new strain harboring a single
construct resulted in an increase in production to 1.2g/L
[9]. In addition to E. coli, 1-butanol production has been
investigated in Pseudomonas putida, Bacillus subtilis,a n dS.
cerevisiae [10, 11], although production in E. coli h a st h u sf a r
shown the most promise. Each of these processes, however,
is far from industrial feasibility, as yields (∼0.05g/g) and
productivities (∼0.01g/L/h) must increase signiﬁcantly to
match the same ﬁgures for corn ethanol (∼0.5g/g and
2g/L/h). The advancement of these processes is thought to
be limited by the low activity of pathway enzymes due to
poor expression, solubility, or oxygen sensitivity, as well as
the metabolic imbalance introduced by these heterologous
pathways. While productivity in each of these platforms is
low in comparison with Clostridial fermentation, the ability
to engineer and manipulate these user-friendly hosts will
facilitate the development of these processes.
2.2. Nonfermentative Higher Alcohols. The production of
biofuels from native organisms can present unique chal-
lenges to synthetic biologists as oftentimes the availability
of genetic tools and physiological knowledge of the hosts
is limited. Additionally, the engineering of heterologous
hosts for biofuel production may decrease the overall ﬁtness
of the cell and require delicate pathway balancing that is
oftentimes diﬃcult [7]. It is therefore advantageous to use
nativepathwaystogenerateimmediateprecursorsforbiofuel
production. This was accomplished in E. coli by using the
hosts’ amino acid biosynthesis pathways to generate 2-keto
acid precursors, which can be converted to alcohols through
a single heterologous reaction (Figure 1). These alcohols
can serve as direct replacements to gasoline, or can be
polymerized to form a variety of potential fuel molecules
[39]. Expression of keto acid decarboxylase (KDC) from
Lactococcus lactis enabled E. coli to convert these 2-keto
acids to aldehydes, which can be reduced to alcohols using
alcohol dehydrogenase (ADH) [13]. A total of 6 of these
higher chain alcohols were detected after expression of KDC.
The production of isobutanol, in particular, was able to
surpass 20g/L after host optimization and ampliﬁcation of
genes responsible for the synthesis of 2-ketoisovalerate, the
precursor to both isobutanol and valine [13]. Subsequent
eﬀorts have also been made to engineer the production of 1-
propanol and 1-butanol [40], 2-methyl-1-butanol [41], and
3-methyl-1-butanol [42].
An alternative and more direct route to 2-ketobutyrate,
the citramalate pathway from Methanococcus jannaschii,w a s
utilized to produce 1-butanol and 1-propanol independently
of threonine. By leveraging a growth selection based on
a requirement for 2-keto acids, the directed evolution of
citramalate synthase was able to enhance the activity of this
heterologous pathway and increase the production of 1-
propanol and 1-butanol by 9-fold and 22-fold, respectively
[43] .T h e s ep a t h w a y sw e r ea l s oe x p a n d e dt op r o d u c el o n g e r
chain alcohols from nonstandard 2-keto acids. These longer
chain alcohols can be used as commodity chemicals and
also possess advantageous fuel properties similar to other
high chain alcohols. The leucine biosynthesis pathway was
engineered to catalyze the elongation of larger substrates by
mutation of LeuA [44]. Similarly, KDC was also designed
to ﬁt larger substrates, after which E. coli was able to
produce several longer chain alcohols from C5–C8 from
these nonstandard 2-keto acids [44].
One distinct advantage in the production of these
alcoholsistheabilitytoapplyexistingaminoacidproduction
technology. Amino acids are produced microbially from
several microorganisms, yet Corynebacterium glutamicum
has been the most successful host for the production of
many amino acids, including valine [45]. In addition to
industrial success in amino acid production, C. glutamicumJournal of Biomedicine and Biotechnology 3
shows an increased tolerance to isobutanol relative to E. coli,
making the production of isobutanol from C. glutamicum
promising. Optimization of the host by gene deletion and
overexpression of isobutanol synthesis genes resulted in
the production of 4.9g/L of isobutanol from glucose [46].
Similarly, an amino acid strain development technique was
adapted for the production of 3-methyl-1-butanol (3MB),
which shares a common precursor with leucine. Whole cell
mutagenesis and selection with a leucine analogue resulted
in a strain able to produce 2.8g/L 3MB, greater than a 5-fold
improvement from wild-type (WT) [47]. Addition of an in
situ extraction technique to remove 3MB from the aqueous
culture media resulted in the production of 9.5g/L of 3MB
[47].
2.3. Isoprenoids. Isoprenoids represent a diverse group of
hydrocarbons synthesized from the C5 isomers isopentyl
diphosphate(IPP)anddimethylallyldiphosphate(DMAPP).
These precursors can be produced from acetyl coenzyme A
(CoA) via the mevalonate pathway or from glyceraldehyde-
3-phosphate and pyruvate through the methylerythritol
pathway (MEP) (Figure 1). Isoprenoids are found naturally
ashormones,photosyntheticpigments,andavarietyofother
specialized secondary metabolites, and have been previously
investigated as nutraceuticals [48] and pharmaceuticals [49].
Because isoprenoids possess vast structural diversity, includ-
ing saturated, unsaturated, branched, or cyclic alkenes or
alkanes,theirpotentialasfuelcandidates,suchasisopentenol
(C5) for motor gasoline, or farnesene (C15) for diesel fuel, is
promising [3].
Recently, the production of isopentenol (3-methyl-3-
buten-1-ol or 3-methyl-2-buten-1-ol), a C5 unsaturated
alcohol, has been investigated in E. coli. Isopentenol can
be produced by the dephosphorylation of the isoprenoid
building blocks IPP and DMAPP (Figure 1). By screening a
Bacillus subtilis genomic library for relief of prenyl diphos-
phate (IPP and DMAPP) accumulation, two isopentenol
biosynthetic genes, nudF and yhfR, were identiﬁed [14]. By
overexpressionof nudF inapreviouslyoptimizedstrain[50],
production of isopentenol reached 110mg/L [14]. Although
the production of isoprenoid fuels is still limited, synthetic
biology can provide the framework for improving isopen-
tenol production as well as the development of processes for
other potential isoprenoid fuels.
2.4. Lipids. The fatty acid biosynthesis pathways are of
great importance to the production of renewable fuels.
Fatty acids are commonly used now in the synthesis of
biodiesel, and the production of long chain alkanes, alkenes,
aldehydes, and alcohols oﬀer promise in the development of
alternative diesel and jet fuels. The fatty acid elongation cycle
begins with the carboxylation of acetyl-CoA to malonyl-
CoA. After transacylation of acetyl-CoA and malonyl-CoA
to acyl carrier protein (ACP), acetyl-ACP and malonyl-
ACP are condensed into acetoacetyl-ACP. After a reduction,
dehydration,andsecondreductionreaction,asaturatedfatty
acyl-ACP (butyryl-ACP) is formed. In eachsubsequentelon-
gation cycle, malonyl-ACP is condensed with the saturated
fatty acyl-ACP to add 2 carbons to the growing hydrocarbon.
After elongation, these hydrocarbons can be released as free
fatty acids by a thioesterase. Additionally, fatty acyl-CoA can
be reduced to a fatty aldehyde, which itself can be reduced to
a fatty alcohol, or decarbonylated to an alkane or alkene [51]
(Figure 1).
The microbial production of biodiesel has been ap-
proached from two angles First, by producing short chain
alcohols and performing the transesteriﬁcation in vivo with
exogenously added fatty acids, and second, by producing
free fatty acids that can be harvested for transesteriﬁcation
in vitro.T h ein vivo production of biodiesel using endo-
geneously produced ethanol was recently demonstrated in
E. coli. Expression of the ethanol production pathway from
Zymomonas mobilis, along with a broad substrate range
acyltransferase (AtfA) from Acinetobacter baylyi, lead to the
production of 1.3g/L of fatty acid ethyl esters (FAEE) after
addition of exogenous oleic acid [18].
Research on the production of fatty acids have centered
around the discovery of oligeanous algae, yeast, and even
bacteria, in which the lipid content, mainly composed of
triacylglycerols (TAG), can reach 60%–80% of the total
biomass produced [51, 52]. The identiﬁcation of the genetic
elements involved in fatty acid synthesis and the imple-
mentation and development of synthetic biology tools to
facilitate strain development will become critical for process
reﬁnement [51]. Recently, eﬀorts have also been made to
produce fatty acids from user-friendly organisms such as E.
coli. The overexpression of an endogenous and exogenous
thioesterase along with acetyl-CoA carboxylase in a ΔfadD
strainresultedintheproductionof2.5g/Loffattyacidsfrom
glycerol [16]. By redesigning the expression of these genes
the production of fatty acids was increased to 4.5g/L at a 6%
yield with a speciﬁc productivity of 0.04g/h/g dry cell weight
[17].
Although each of these approaches has been successful
in producing precursors for biodiesel synthesis, the supply
of raw materials (lipid) or downstream processing (transes-
teriﬁcation) can be cost-intensive [18]. It would be advanta-
geous, therefore, to create a consolidated process to reduce
costs. Consolidated bioprocessing (CBP), which involves the
simultaneous production of saccharolytic enzymes with the
hydrolysis of pretreated biomass and the fermentation of
hexose and pentose sugars [53], signiﬁcantly reduces pro-
cessing costs by converting abundant, inexpensive biomass
into useful fuels or chemicals in a single step. Unfortunately,
noorganismspossessboththeabilitytodigestlignocellulosic
biomass and ferment sugars to fuels at high yields. The
solution to this challenge is being approached in two
directions: the introduction of high yield fuel production
pathways into cellulolytic organisms, and the engineering of
substrate (lignocellulosic) utilizing pathways into organisms
withsuperiorproductformation.Muchoftheworkuntilthis
point has focused around the production of ethanol [53, 54],
until recently when this strategy was applied by engineering
E. coli for the production of biodiesel (FAEE), fatty alcohols,
andwaxesters[15].E.coliwaschosenasahostduetoitshigh
fatty acid synthesis rate (0.2g/L/h/g dry cell mass [51]) and
straightforwardness in genetic manipulation. As in previous4 Journal of Biomedicine and Biotechnology
studies,theethanolproductionpathwayfromZ.mobilis(pdc,
adhB) was overexpressed to produce ethanol for FAEE pro-
duction. By combining this pathway with a cytosolic version
of an endogenous thioesterase (‘tesA) and an ester synthase
fromA.baylyi(atfA),afattyacidoxidation deﬁcientstrainof
E. coli (ΔfadE) was able to produce 37mg/L of FAEE directly
from glucose [15]. To increase the production of FAEE, two
CoA ligases, fadD from E. coli and FAA2 from S. cerevisiae,
were overexpressed along with another copy of atfA to bring
productionofFAEEupto674mg/L[15].Inordertomitigate
the cost of processing of raw cellulosic biomass into reﬁned
sugars, this process was engineered to use xylan, a pentose
polysaccharide component of hemicellulose. Expression of
the endoxylanase xyn10B from Clostridium stercorarium and
the xylanase xsa from Bacteroides ovatus as chimeras with
OsmY allowed E. coli to grow on xylan as a sole carbon
source[15]. Assembly of thexylan degradation pathway with
the previously described FAEE production strain resulted
in a strain able to produce 12mg/L of FAEE from xylan
[15]. Future work may focus on the development of secreted
cellulases to increase the substrate utilization capacity of
E. coli, in addition to optimizing the fatty acid pathway
by prospecting for enzymes or expression systems with
increased activity or stability. This work demonstrates the
ﬁrst consolidated process for the production of fatty acid
based fuels and chemicals from complex polysaccharides,
and while the process yields and productivity remained to
be improved to merit commercialization, this work gives
engineers and synthetic biologists the foundation to advance
this process.
2.5. Direct Incorporation of CO2. The role of photosynthesis
in any biofuel production process is critical. Many current
technologies, such as biomass derived biofuels and algal
lipids, have received attention as viable fuel replacement
technologies [55, 56], yet rely on intermediate stages to
incorporate CO2 or recover biomass to process precursors
into useable fuels, which can increase costs. Photosynthetic
organisms such as cyanobacteria, algae, and plants use light
energy to generate reducing power to directly incorporate
CO2 into organic metabolites. The use of these organisms to
directly produce fuels can limit production costs and CO2
emissions during intermediate processing, and may also help
reduce net CO2 emissions by scrubbing CO2 enriched ﬂue
gases from traditional power plants and producing useful
fuels or chemicals, although their potential is not limited to
this scenario. Initial eﬀorts have focused on the production
of ethanol in Rhodobacter [57]a n dSynechococcus [58].
The production of advanced biofuels such as isobu-
tyraldehyde, isobutanol, and isoprene has recently been
investigated in cyanobacteria. This was ﬁrst demonstrated
by transferring the 2-keto acid pathways to higher chain
alcohols into the cyanobacterium Synechococcus elongatus
(Figure 2). Isobutyraldehyde was chosen as an initial tar-
get since its boiling point (63◦C) allows it to be easily
stripped from the culture medium, thus avoiding any tox-
icity eﬀects. Chromosomal integration of 2-ketoisovalerate
biosynthesis genes (alsS, ilvCD) and 2-ketoisovalerate decar-
boxylase (kivd) resulted in the production of 723mg/L
of isobutyraldehyde from dissolved CO2 (NaHCO3)[ 19].
To improve the low activity of ribulose-1,5-bisphophate
carboxylase/oxygenase (RubisCO), the rbcLS genes from a
similar cyanobacterium were integrated downstream of the
endogenous rbcLS genes. Production of isobutyraldehyde
in this strain was elevated to 1.1g/L, with a productiv-
ity of 6.2mg/L/h [19], an encouraging ﬁgure considering
microalgal biodiesel has been estimated to be near 4mg/L/h
[19]. The production of isobutanol was also investigated
by expressing the NADP+ dependent alcohol dehydrogenase
YqhD from E. coli. The production of isobutanol reached
450mg/L, and although encouraging, is currently thought to
be limited by end product toxicity [19].
A similar study was also recently conducted in which
the isoprenoid biosynthesis pathways were exploited for
biofuel production in the cyanobacterium Synechocystis sp.
PCC6803 (Figure 2). The volatile hydrocarbon isoprene,
mostnotablyproducedinplants[59],isapotentialfeedstock
for biofuel or chemical production. The ispS gene from
kudzu vine (Pueraria montana), encoding for an isoprene
synthase, which catalyzes the conversion of DMAPP to
isoprene, was codon optimized and cloned into Synechocystis
under the control of a light dependent promoter. Expression
of ispS under high intensity light resulted in a small accu-
mulation of isoprene (50µg/day/g dry cell mass) [20]r e l a t i v e
to healthy oak leaves (∼1,650µg/day/g dry cell mass) [60],
demonstrating that while successful, this process remains to
be improved.
A signiﬁcant obstacle to biofuel production in photo-
synthetic organisms is the design of scale up processes.
Photosynthetic organisms require more complex reactor
designs and their growth and productivity in suboptimal
conditions (temperature, salt concentration, etc.) is not well
understood. However, two reactor designs in use today, the
raceway pond and the photobioreactor, have shown promise
in their ability to accumulate photosynthetic biomass using
sunlight [61]. The raceway pond is inexpensive and simple
to construct, but it is subject to contamination and is
less photosynthetically eﬃcient than a photobioreactor.
Photobioreactors,havingseveraldesigns[62],haveincreased
capital costs compared to raceway ponds, but have superior
productivities due to their increased biomass concentration,
and therefore, greater photosynthetic eﬃciency. Hybrid sys-
temscomprisedofbothracewaypondsandphotobioreactors
have also been investigated to maximize the advantages of
each design [62].
3. Synthetic Biology for Biofuels
Synthetic biology is an increasingly expanding discipline
focusing on the design and construction of artiﬁcial systems
to achieve a desired goal. These systems are derived from
the assembly of standardized components in a hierarchal
manner to create a population of programmed cells car-
rying out a desired function [31]. For biofuels, this is of
particular interest as the production of these chemicals
requires eﬃcient integration of foreign genes and pathways
into central metabolism. Delicate optimization and ﬁne-







































Figure 1: Metabolic schematic for biofuel production. Biofuel production pathways for traditional fermentative processes (grey),
nonfermentative higher chain alcohols (green), isoprenoid fuels (blue), and fatty acid fuels (red) from central metabolism. Abbreviations:
2KB (2-ketobutyrate), 2KIV (2-ketoisovalerate), 2KIC (2-ketoisocaproate), 2MB (2-methyl-1-butanol), 3MB (3-methyl-1-butanol), ACP
(acylcarrierprotein),CoA(coenzymeA),DMAPP(dimethylallyldiphosphate),FAEE(fattyacidethylester),FAME(fattyacidmethylester),
FFA (free fatty acid), G3P (glyceraldehyde-3-phosphate), IPP (isopentyl diphosphate), and OAA (oxaloacetate).
yield is of equal concern as the viability of any biofuel
processes is extremely sensitive to production costs [3], such
as raw material supply, total production, and downstream
processing. Synthetic biology can provide tools and design
principles to guide the development of such processes
(Figure 3).
A goal of synthetic biology is to create a library of
biological parts that can be used independently or as part
of a larger assembly for a higher function. These biological
parts can have simple or complex behaviors relayed through
a variety of outputs such as gene expression. A simple but
powerful example is the design of synthetically regulated
promoters [21–23] to accurately control gene expression.
More complex examples include the modulation of the
expression of multiple genes through tunable intergenic
regions (TIGR) [27], the activation and silencing of gene
expression by riboregulators and ribozymes [24, 26, 28],
or successive increases in gene expression through chromo-
somal ampliﬁcation [63], which will become particularly
importantinthedesignofstablestrainsforindustrialbiofuel
production. Additionally, thermodynamic models have been
developed to rationally design ribosome binding sites to
achieve robust expression levels varying by as much as
100,000 fold [64]. Preliminary designs for these biofuel gene
expression systems will need to evolve to regulate and ﬁne-
tune the gene expression of these pathways,as was previously
discovered for isoprenoids, a pathway discussed earlier for
biofuel production [65]. Synthetic biology has also achieved
the adaptation of posttranslation systems to regulate enzyme
activity such as allosteric protein gates [25] and synthetic
scaﬀolds [30].
The balance between the metabolic capacity of biofuel
production pathways and host ﬁtness will also play a key role
in the productivity and yield of the process. This balancing
of biofuel pathways, which aims to maximize the ﬂow of
carbon toward product formation without drastically alter-
ing the metabolic load or intracellular cofactors (NAD(P)H,
ATP, ACP, etc.) can be achieved through the use of these
synthetic biology tools. This was again demonstrated in the
mevalonate pathway to isoprenoids by employing a synthetic
scaﬀold to increase the metabolic capacity while limiting
protein expression [29]. In addition to the balancing of
biofuel production pathways, the expression of multienzyme
complexes,whichoftenrequiredelicatebalancingofcatalytic
subunits, is of great importance. The most direct example is
the production of complexed cellulases, which will be crucial
to increase the substrate utilization capacity of biomass-
























Figure 2: Metabolic schematic for direct photosynthetic biofuel production. Biofuel production pathways for traditional fermentative
processes (grey), nonfermentative higher chain alcohols (green), isoprenoid fuels (blue), and fatty acid fuels (red) from CO2 through
photosynthesis. Abbreviations: 2KIV (2-ketoisovalerate), 3PG (3-phosphoglycerate), ACP (acyl carrier protein), CoA (coenzyme A),
DMAPP (dimethylallyl diphosphate), G3P (glyceraldehyde-3-phosphate), PSI (photosystem I), PSII (photosystem II), and RuBP (ribulose-
1,5-bisphosphate).
The regulation of ﬂux through divergent or branched
pathways will also be critical, as the balance of carbon and
electronic cofactors such as NADH must be considered to
achieve an eﬃcient process. These divergent pathways are
especially common in the nonfermentative higher chain
alcohol and isoprenoid pathways. To direct carbon ﬂow in
the desired manner, scaﬀolds can be engineered to connect
the preferred branches of the pathway together. Regulatory
RNA molecules can also be employed to minimize the
expression of competing but essential pathways. Product
yields may also be dramatically aﬀected by the availability
of NADH or NADPH. One possible solution is to engineer
pathwayswithalternativecofactorspeciﬁcitytoincreasetheir
availability [66] or interconversion [67].
Synthetic biology will also be key in rewiring existing
regulation. The design of new regulatory pathways from
synthetic genetic elements will be important in sensing the
extracellular or intracellular environment and producing
a programmed cellular response. For biofuel production
from lignocellulosic biomass, this is of great importance as
theeﬃcientuptak eofamixtur eofhex oseandpent osesugars
simultaneously is desirable. Synthetic biology can provide
toolstoconstructnewcircuitsdevoidofun wantedregulation
from the bottom up [68] to sense the extracellular envi-
ronment and produce the necessary response to digest the
sugars. Ultimately, the bottom-up construction of biological
circuitsmayextendbeyondindividualpathwaystowardallof
metabolism, as the synthesis of entirely synthetic, replicable,
and functional genomes has recently been accomplished
[69].Inthefuture,thiswillallowsyntheticbiologiststobuild
heterologous pathways into organisms devoid of unwanted
pathways or properties, therefore, increasing the selectivity
and yield of the process.
The development and optimization of many aspects of
biofuel production technology can beneﬁt from the work
already accomplished through synthetic biology. As theJournal of Biomedicine and Biotechnology 7






























































of biofuel production processes.
number of available tools increases, the standardization
of these parts will become increasingly important. One
of the current challenges facing synthetic biology is the
reproducibility of the developed tools in diﬀerent systems, as
the variability in cellular regulation and physiology can vary
greatly from host to host. Proposals for standardization have
been made [70], although as the complexity of these systems
increasesowilltheirvariability.However,currenttechnology
developed by synthetic biology has already allowed for the
successful design of many heterologously expressed biofuel
production and substrate utilization pathways extending
beyond the most user-friendly organisms. The advance-
ment of synthetic biology toward new diagnostic tools
and high throughput screening systems will aid in the
further development of these biofuel processes for pathway
optimization and enzyme discovery or improvement. The
success that synthetic biology has already aﬀorded biofuel
production technology lends conﬁdence to future synergistic
developments and breakthroughs.
4. Conclusions
The desire for renewable liquid fuel replacements to
petroleum has steadily increased with concerns about the
current fuel economy’s stability and environmental impact.
The development of new biofuel production processes has
sought to mitigate some of these issues. These fuels, whether
designed for motor gasoline, diesel fuel, or jet fuel, will
face challenges in strain development and productivity in a
cost-sensitive market. The integration of synthetic biology
with the development of these processes will be signiﬁcant
in bringing the biofuels industry from its infancy to a
commercially viable alternative to petroleum.
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